Evidence map›Paper›PMID 42665350›Full record

ArticleBMJ open2026

Perspectives of gastroenterologists on the evolving epidemiology and management of non-alcoholic fatty liver disease in Pakistan: a qualitative study.

Muhammad Ebad Khan, Matti Ullah, Muhammad Usman Khan, Alishba Bibi, Nayyab Tariq, Adina Mahnoor, Muqaddas Rasool, Maryam Nasir, Raja Ahmad Sohaib, Waqas Ahmed and 4 more

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Muhammad Ebad KhanDepartment of Pharmacy Practice, Faculty of Pharmacy, Hamdard University - Islamabad Campus, Islamabad, Pakistan m.ebad0316@gmail.com.ORCID 0009-0001-0007-0469
Matti UllahDepartment of Pharmacy Practice, Faculty of Pharmacy, Hamdard University - Islamabad Campus, Islamabad, Pakistan.ORCID 0000-0002-5253-1538
Muhammad Usman KhanPharmacy, Iqra University - Islamabad Campus, Islamabad, H-9 Campus, Pakistan.
Alishba BibiBachelor of Generic Nursing, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology - Islamabad Campus, Islamabad, Pakistan.
Nayyab TariqPharmacy, Iqra University - Islamabad Campus, Islamabad, H-9 Campus, Pakistan.
Adina MahnoorPharmacy, Iqra University - Islamabad Campus, Islamabad, H-9 Campus, Pakistan.
Muqaddas RasoolPharmacy, Iqra University - Islamabad Campus, Islamabad, H-9 Campus, Pakistan.
Maryam NasirPharmacy, Iqra University - Islamabad Campus, Islamabad, H-9 Campus, Pakistan.
Raja Ahmad SohaibDepartment of Pharmacy Practice, Faculty of Pharmacy, Hamdard University - Islamabad Campus, Islamabad, Pakistan.
Waqas AhmedGastroenterology, Rawalpindi Medical University, Rawalpindi, Pakistan.
Mahnoor AliPharmacy, Iqra University - Islamabad Campus, Islamabad, H-9 Campus, Pakistan.
Malaika NasirPharmacy, Iqra University - Islamabad Campus, Islamabad, H-9 Campus, Pakistan.
Uzma NawazPharmacy, Iqra University - Islamabad Campus, Islamabad, H-9 Campus, Pakistan.
Muhammad Abu HurairahPharmacy, Iqra University - Islamabad Campus, Islamabad, H-9 Campus, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore gastroenterologists' perspectives on the changing epidemiology of non-alcoholic fatty liver disease (NAFLD) in Pakistan and identify barriers to its diagnosis and management.

designQualitative exploratory study using face-to-face semi-structured in-depth interviews. SETTINGS: Public and private healthcare settings in Islamabad, Rawalpindi and surrounding regions of Pakistan.

participants22 consultant gastroenterologists and postgraduate trainees in gastroenterology registered with the Pakistan Medical and Dental Council, with over 2 years of clinical experience managing patients with NAFLD. Participants were recruited through purposive sampling. PRIMARY AND SECONDARY OUTCOMES: Primary outcomes included physicians' perceptions of epidemiological changes, risk factors, clinical presentation patterns and barriers to NAFLD care. Secondary outcomes included proposed strategies for prevention and management.

resultsFive major themes emerged from thematic analysis: (1) changing epidemiology-alarming rises in prevalence, demographic shift toward younger adults (20-30 years), and increasing presentation with advanced disease; (2) multifactorial risk factors-poor diet, sedentary lifestyle, metabolic comorbidities including diabetes and obesity, hypertension and genetic-hormonal influences; (3) clinical presentation-asymptomatic early disease with incidental detection, non-specific symptoms, and distinct gender-occupational patterns (housewives, post-menopausal women, sedentary professionals); (4) significant barriers to care-profound patient unawareness, poor compliance with lifestyle modifications, diagnostic limitations (FibroScan unavailability) and financial constraints restricting access to advanced diagnostics and pharmacotherapy (pharmacotherapy including newer agents such as Resmetirom for metabolic dysfunction-associated steatohepatitis); (5) proposed strategies-public awareness campaigns, targeted screening programmes, lifestyle modification and multidisciplinary collaborative care models.

conclusionNAFLD in Pakistan represents a silent epidemic with alarming epidemiological shifts towards younger populations and advanced disease. Urgent implementation of multifaceted strategies including public awareness campaigns, targeted screening of at-risk populations and multidisciplinary collaborative care models is imperative.

Indexed as

Attitude of Health PersonnelGastroenterologistsNon-alcoholic Fatty Liver DiseaseAdultFemaleHumansInterviews as TopicMaleMiddle AgedPakistanPrevalenceQualitative ResearchRisk FactorsEpidemiologyGastroenterologyHealth policyQUALITATIVE RESEARCH

Identifiers

PMID42665350
PMCPMC13536171

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.